Back to Stock Dashboard Sector: Healthcare

HALO

Halozyme Therapeutics Inc

Halozyme Therapeutics Inc is a biotechnology company. It is engaged in research on human enzymes that alter the extracellular matrix and tumor environment.

Quantitative Factor Evaluation • Updated 2026-09-14

Overall Rating
Halozyme Therapeutics Inc stock price  by TradingView
Value

Subscribe to unlock

Growth

Subscribe to unlock

Profitability

Subscribe to unlock

Momentum

Subscribe to unlock

Revisions

Subscribe to unlock

Subscribe to Prism Premium to see every stock, unlock full factor-grade breakdowns, and get B-/A rated picks.

Subscribe to Prism Premium

Underlying Financial Metrics

P/E Ratio
EV / EBITDA
Rev Growth YoY
Gross Margin
Price Return 3M
Price Return 12M
Analyst Up Revisions
Analyst Down Revisions

Historical Factor Score Progression

Date Value Growth Profitability Momentum Revisions Overall
2025-06-30 C+ (2.7) A- (3.9) B+ (3.7) B (3.3) A+ (5.0) B+ (3.7)
2025-03-31 C+ (2.7) B+ (3.8) B+ (3.6) B- (3.1) A+ (5.0) B+ (3.6)
2024-12-31 C+ (2.7) B (3.4) A- (4.0) B- (3.1) A+ (5.0) B+ (3.6)
2024-09-30 C+ (2.6) B+ (3.8) A- (3.9) B- (3.1) A+ (5.0) B+ (3.7)
2024-06-30 C+ (2.7) C (2.3) B+ (3.6) B- (3.1) A+ (5.0) B (3.4)

Recent News